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Coenzyme A (CoA) is an obligatory cofactor in all branches of life. CoA and its derivatives
are involved in major metabolic pathways, allosteric interactions and the regulation of
gene expression. Abnormal biosynthesis and homeostasis of CoA and its derivatives
have been associated with various human pathologies, including cancer, diabetes and
neurodegeneration. Using an anti-CoA monoclonal antibody and mass spectrometry, we
identiﬁed a wide range of cellular proteins which are modiﬁed by covalent attachment of
CoA to cysteine thiols (CoAlation). We show that protein CoAlation is a reversible post-
translational modiﬁcation that is induced in mammalian cells and tissues by oxidising
agents and metabolic stress. Many key cellular enzymes were found to be CoAlated in
vitro and in vivo in ways that modiﬁed their activities. Our study reveals that protein
CoAlation is a widespread post-translational modiﬁcation which may play an important
role in redox regulation under physiological and pathophysiological conditions.
Introduction
Coenzyme A (CoA) is a ubiquitous and essential cellular cofactor synthesised from cysteine, panto-
thenate (Vitamin B5) and ATP in a pathway conserved in all cells. CoA functions as a master acyl
group carrier and a carbonyl-activating group, resulting in numerous metabolically active thioester
derivatives, including acetyl CoA, malonyl CoA, succinyl CoA and 3-hydroxy-3-methylglutaryl CoA,
among many others. CoA and its derivatives play important roles in a diverse range of cellular pro-
cesses, including the Krebs cycle, the synthesis and oxidation of fatty acids, ketogenesis, biosynthesis
of cholesterol and acetylcholine, regulation of gene expression and cellular metabolism via protein
acetylation and others [1–4]. The size of the CoA pool (CoA and all its derivatives) varies widely
among mammalian cells and tissues, being largest in the liver, heart and kidney. The subcellular distri-
bution of the CoA pool reﬂects its diverse roles and varies from 20–140 mM in the cytosol to 2.2–
5 mM in the mitochondria [1]. The level of CoA and the ratio between CoA and its thioesters (acyl
CoA) in mammalian cells and tissues are tightly regulated by extracellular stimuli, nutrients, intracel-
lular metabolites and stresses. Insulin, glucose, fatty acids and pyruvate all decrease CoA biosynthesis,
whereas fasting, glucagon, glucocorticoids and hypolipidaemic drugs have the opposite effect [5–9].
Changes in the size of the CoA pool have also been reported in pathological conditions, such as dia-
betes and cancer [10,11]. Mutations in pantothenate kinase 2 (PANK2) and CoA synthase (CoASY),
which are rate-limiting enzymes in the CoA biosynthetic pathway, are associated with a severe
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neurodegenerative disorder called NBIA (Neurodegeneration with Brain Iron Accumulation), suggesting that
CoA biosynthesis and homeostasis play a crucial role in maintaining the functional integrity of the central
nervous system [12,13].
Cysteine plays critical roles in protein structure and function by forming inter- and intra-molecular disul-
phide bonds, by co-ordinating metal ions and by participating in catalytic reactions. Protein cysteines are
targets for post-translational modiﬁcations, including S-acylation, oxidation, S-nitrosation, persulfhydration and
S-thiolation [14,15]. During oxidative stress, the thiol group of cysteine residues can be progressively oxidised
to sulphenic, sulphinic or sulphonic states. The latter two modiﬁcations are generally considered to be irrevers-
ible and can lead to the loss of protein function. Alternatively, protein cysteines can form mixed disulphides
with low-molecular-weight thiols such as glutathione (GSH) by S-thiolation. Glutathionylation is the most
studied form of S-thiolation in mammalian cells, which is thought to protect reactive cysteines from irreversible
oxidation [16,17]. Additionally, glutathionylation can modulate catalytic activity, regulatory interactions, subcel-
lular localisation and protein stability, thereby playing a key role in redox signalling and the antioxidant
defence [18].
The nucleophilic thiol of CoA also participates in thiol-disulphide exchange reactions. CoA disulphides or
mixed disulphides with other low-molecular-weight thiols, such as CoA-cysteine and CoA-GSH, have been
identiﬁed in prokaryotic and eukaryotic cells [19]. The formation of mixed disulphides between CoA and
cysteines of speciﬁc proteins has been reported in several biochemical and crystallographic studies [20–22]. For
example, acetyl-CoA acetyltransferase and glutamate dehydrogenase were found to be covalently bound to CoA
in rat liver mitochondria [23], and a CoA-modiﬁed form of a peroxide sensor OhrR was detected in Bacillus
subtilis [21]. However, the extent of covalent protein modiﬁcation by CoA in prokaryotes or eukaryotes, the
induction by oxidative and metabolic stress, and the mechanism of regulation have not been reported.
Experimental
Reagents and chemicals
The generation of the anti-CoA antibody (1F10) was described recently [24]. All common chemicals were
obtained from Sigma–Aldrich unless otherwise stated. The following antibodies and dilutions were used: mouse
anti-CoA antibody (0.17 mg/ml); rabbit anti-actin antibody (Cell Signaling Technology #4968, 1:2000); rabbit
anti-tubulin antibody (Cell Signaling Technology #2148, 1:2000); rabbit anti-glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) antibody (Abcam #ab181602, 1:6000); mouse anti-GSH antibody (Millipore
#MAB5310, 1:1000) and rabbit anti-pyruvate dehydrogenase kinase 2 (PDK2) antibody (Abcam #ab68164,
0.5 mg/ml). Primary antibodies were diluted in Odyssey blocking buffer containing 0.01% Tween 20. Secondary
antibodies [Alexa Fluor 680 goat anti-mouse IgG H&L (Life Technologies) and IRdye 800 CW goat anti-rabbit
IgG H&L (LI-COR Biosciences)] were diluted in Odyssey blocking buffer (1:10 000) containing 0.02% sodium
dodecyl sulphate (SDS).
Cardiomyocyte preparation and treatment
Cardiomyocytes were puriﬁed as previously described [25]. Cardiomyocytes were incubated in the presence or
absence of hydrogen peroxide (H2O2, 1–100 mM), t-butylhydroperoxide (TBH, 1 mM), menadione (25 mM) or
diamide (0.5 mM) in incubation buffer [156 mM NaCl, 2 mM KCl, 2 mM MgSO4, 1.25 mM K2HPO4, 2 mM
CaCl2, 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 10 mM D-glucose, pH 7.4] for 30
min at 37°C. The reaction was stopped by perchloric acid (PCA, 3.5% ﬁnal). PCA precipitates were collected by
centrifugation (21 000 g for 20 min at 4°C) and resolubilised in solubilisation buffer [100 mM Tris–HCl (pH
7.5), 5 mM ethylenediaminetetraacetic acid (EDTA), 0.5% SDS and 8 M urea] supplemented with 25 mM
N-ethylmaleimide (NEM) before Western blot analysis.
Generation of HEK293/pantothenate kinase 1β cell line
The pET28a-LIC containing human Pank1β (pantothenate kinase 1β) insert was purchased from Addgene.
The insert lacks the ﬁrst 28 bases and the last 3 bases of the full-length human Pank1β coding sequence. The
missing bases were introduced by PCR using the following primers which were also designed to introduce an
EcoR1 restriction site at the 50-terminus and a Not1 restriction site at the 30-terminus of the ampliﬁed
sequence: 50-GATCAGAATTCACCATGAAGCTTATAAATGGCAAAAAGCAAACATTCCCATGGTTTGGCA
TGGAC-30 (forward) and 50-ACTCGGCGGCCGCTACTTGTCATCAGTCATTTTGAACAGTT (reverse). The
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PCR was performed using Pfu DNA polymerase (Thermo Scientiﬁc) and DNA Engine DYAD™, Peltier
Thermal Cycler (MJ Research). The PCR product was digested and cloned into pET30a using standard proce-
dures. The plasmid was sequenced and the resulting full-length human Pank1β sequence was used for the
generation of a lentiviral construct. PCR was performed with the following primers to introduce Not1 and
Mlu1 restriction sites at the start and end of the sequence, respectively, as well as to introduce an N-terminal
EE-tag in the expressed protein: 50-CACAAGCGGCCGCACCATGGAGTTCATGCCGATGGAGAAGCTTA
TAAATGGCAAAAAGCAA-30 (forward) and 50-CACGGACGCGTCTACTTGTCATCAGTCATTTTGA-30
(reverse). The ampliﬁed sequence was puriﬁed by ethanol precipitation, digested with Not1 and Mlu1 (New
England Biolabs) and ligated into pLEX vector (Invitrogen) using the T4 Rapid ligation kit (Thermo
Scientiﬁc). The plasmid was propagated in XL10-Gold Escherichia coli competent cells (Agilent
Technologies), puriﬁed using the QIAprep Spin Miniprep Kit (Qiagen) and used for transfection. HEK293
cells at 70–80% conﬂuence, on 10 cm tissue culture plates were co-transfected with 5.4 mg of pLEX/Pank1β
or pLEX-MCS (empty vector), and 3.5 mg of pLP-1, 1.3 mg of pLP-2 and 1.8 mg of VSVG packaging plasmids
using ExGene500 (Invitrogen). The the next day, culture medium containing ExGene500/DNA complexes
was removed and replaced with 10 ml of complete culture medium without antibiotics. Cells were incubated
at 37°C for 48 h and culture medium containing recombinant lentiviruses was collected, ﬁltered through a
Millex-HV 0.45 mm syringe ﬁlter and stored at −80°C. The stable cell lines were generated using puromycin
selection. HEK293 cells were cultured in 6-well tissue culture plates to reach 50–60% conﬂuence on the day
of infection. 1 ml of the viral stock was added directly into the wells pre-ﬁlled with 1 ml of fresh Dulbecco’s
Modiﬁed Eagle’s Medium (DMEM), and cells were incubated at 37°C, 5% CO2. After 48 h, culture medium
containing lentivirus was removed and replaced with selection medium (DMEM with 2 mg/ml puromycin).
At the end of the selection procedure, stable overexpression of Pank1β protein expression was conﬁrmed by
Western blot using an anti-EE antibody.
Treatment of HEK293/Pank1β cells
Approximately 0.4–1 million HEK293 or HEK293/Pank1β cells were seeded onto 60 mm culture dishes and
allowed to grow for 24 h in DMEM (Lonza) supplemented with 10% foetal bovine serum (FBS, Hyclone),
50 U/ml penicillin and 0.25 mg/ml streptomycin (Lonza). The medium was replaced with pyruvate-free DMEM
supplemented with 5 mM glucose and 10% FBS, and cells were incubated for a further 24 h. Cells were then
treated with H2O2 (0.5 mM), menadione (50 mM), phenylarsine oxide (PAO, 10 mM), diamide (0.5 mM) and
TBH (1 mM) for 30 min at 37°C in pyruvate-free DMEM supplemented with 5 mM glucose. For the recovery
experiments, after incubation with H2O2 or diamide as above, cells were washed with and left to recover for up to
90 min in pyruvate-free DMEM supplemented with 5 mM glucose. For testing the effect of antioxidants, cells were
incubated with 5 mM N-acetylcysteine or 1 mM Vitamin C in pyruvate-free DMEM supplemented with 5 mM
glucose 2 h prior to diamide treatment (0.5 mM, 30 min). For testing the effect of nutrients, cells were incubated
in pyruvate-free DMEM supplemented with glucose (0–40 mM), pyruvate, galactose, lactate or Vitamin C (all at 5
or 20 mM) for 18 h. After treatments, cells were collected by pressure washing and centrifugation (956 g for 5 min
at 4°C). The medium was removed and cells were lysed in ice-cold lysis buffer (homogenisation buffer containing
1% Triton X-100) supplemented with protease inhibitor cocktail (PIC) and 25 mM NEM. Lysates were centrifuged
at 21 000 g for 5 min at 4°C and the supernatant was analysed by Western blotting.
Transient transfection and immunoprecipitation
HEK293 and HEK293/Pank1β cells were transfected with Origene’s pCMV6-Entry vectors encoding
FLAG-tagged full-length human GAPDH, creatine kinase (CK), isocitrate dehydrogenase 2 (IDH2) or PDK2
using the Turbofect transfection reagent (Thermo Scientiﬁc) according to the manufacturer’s instructions.
FLAG-tagged proteins were immunoprecipitated from cell lysates (lysis buffer + 25 mM NEM) using an
anti-FLAG antibody (Sigma–Aldrich) and Protein G Sepharose. Endogenous HMG-CoA synthase 2
(HMGCS2) and 3-ketoacyl-CoA thiolase (ACAA2) were immunoprecipitated using rabbit monoclonal anti-
bodies to HMGCS2 and ACAA2. Immunoprecipitated proteins were eluted with 2× loading buffer supplemen-
ted with 25 mM NEM and analysed by anti-CoA western blots.
Western blotting
Samples of tissue/cell lysates containing ∼30–40 mg of proteins were mixed with SDS loading buffer [ﬁnal con-
centrations: 63 mM Tris–HCl (pH 6.8), 10% glycerol, 2% SDS and 0.0025% bromophenol blue] with or
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without dithiothreitol (DTT, 100 mM ﬁnal) and heated for 5 min at 99°C. Resolubilised protein samples from
cardiomyocytes were incubated in loading buffer and DTT at room temperature (RT) for 10 min. Proteins were
separated by SDS-polyacrylamide gel electrophoresis (PAGE) on 4–20% Mini-PROTEAN TGX Precast Gels
(Bio-Rad Laboratories) and transferred to low-ﬂuorescence polyvinylidene ﬂuoride (PVDF) membranes
(Bio-Rad Laboratories). Membranes were blocked with Odyssey blocking buffer (LI-COR Biosciences). Protein
bands were visualised using infrared dye-conjugated secondary antibodies and the Odyssey infrared imaging
system (Odyssey Scanner CLx and Image Studio Lite software, LI-COR Biosciences).
Animals
Animals used were male Sprague–Dawley rats (120–300 g) bred at University College London. All experiments
involving animals were performed in accordance with the European Convention for the Protection of
Vertebrate Animals used for Experimental and Other Scientiﬁc Purposes (CETS no.123) and the UK Animals
(Scientiﬁc Procedures) Act 1986 amendment regulations 2012.
Heart perfusion
Heart perfusion was performed as previously described except that 11 mM glucose and 1.8 mM CaCl2 were
added to Krebs–Henseleit bicarbonate (KHB) and bovine serum albumin (BSA) was omitted [26]. Hearts were
perfused with KHB for 10 min followed by 20 min perfusion with KHB in the presence or absence of 100 mM
H2O2. Hearts were freeze-clamped with tongs pre-cooled in liquid N2. Frozen hearts were powdered in liquid
N2 and homogenised in ice-cold homogenisation buffer [50 mM Tris–HCl (pH 7.5), 150 mM NaCl, 5 mM
EDTA, 50 mM NaF and 5 mM Na4P2O7] supplemented with 25 mM NEM and PIC (Roche) using a tissue dis-
integrator. Triton X-100 was added (1% ﬁnal) and the homogenate was mixed well before centrifuging at 21
000 g for 5 min at 4°C. The supernatant was analysed by Western blotting.
Liver sample preparation
Rats were starved for 24 h with constant access to water or fed a high-fat/high-sucrose (HF/HS) diet containing
35.5% fat and 36.6% carbohydrate for a week (D09071702, Research Diets, Inc.). Rats were anaesthetised with
pentobarbitone (300 mg/kg of body weight), and livers were removed and immediately freeze-clamped using
tongs pre-cooled in liquid N2. Frozen livers were powdered in liquid N2 and homogenised in ice-cold hom-
ogenisation buffer supplemented with 25 mM NEM and PIC using a tissue disintegrator. SDS was added (1%
ﬁnal), and the homogenate was sonicated to reduce viscosity before centrifuging at 21 000 g for 5 min at RT.
The supernatant was analysed by western blotting.
Enzyme activity assays
CK (rabbit muscle, Roche #127 566; 7.2 mg/ml) was incubated with or without 10 mM CoASSCoA (CoA disul-
phide) or GSSG in 50 mM Tris–HCl (pH 7.5) at RT for 20 min. Samples were then incubated with or without
DTT (45 mM ﬁnal) at RT for 5 min. A 5 ml aliquot of the incubation mixture was diluted to a ﬁnal volume of
200 ml with assay buffer which consisted of hexokinase 3.3 mU/ml (yeast, Roche #1 426 362), 1.7 mg/ml
GAPDH (yeast, Roche catalogue #127 655), 2 mM NADP, 2 mM ADP, 20 mM glucose, 2 mM EDTA, 10 mM
magnesium acetate, 422.5 mM triethanolamine (TEA; pH 7.6) and 60 mM phosphocreatine. CK activity was
determined by measuring the increase in absorbance of NADPH at 340 nm at 30°C for 10 min using a Tecan
plate reader.
GAPDH (rabbit muscle, Sigma–Aldrich #G2267) was incubated at 15 mg/ml with or without 10 mM
CoASSCoA or GSSG in the presence or absence of 15 mM DTT in 70 mM KH2PO4 (pH 7.6) for 1 min on ice.
A 5 ml aliquot of the incubation mixture was diluted to a ﬁnal volume of 150 ml with assay buffer which con-
sisted of 82.6 mM KH2PO4 (pH 7.6), 6.6 mM 3-phosphoglyceric acid, 1.1 mM ATP, 20 mM NADH, 0.9 mM
EDTA, 1.6 mM MgSO4 and 29.2 mg/ml 3-phosphoglyceric phosphokinase (from Baker’s yeast, Sigma–Aldrich
#P7634). The assay buffer was incubated at 30°C for 10 min before the addition of GAPDH. GAPDH activity
was determined by measuring the decrease in absorbance of NADH at 340 nm at RT for 10 min using a Tecan
plate reader.
NADP-dependent IDH from porcine heart (Sigma–Aldrich #I1877) (1.1 mg/ml) was incubated with or
without 10 mM CoASSCoA or GSSG in the presence or absence of 20 mM DTT in 30 mM Tris–HCl (pH 7.5),
90 mM NaCl, 0.6 mM MgCl2 and 0.6 mM MnCl2 at RT for 20 min. A 5 ml aliquot of the incubation mixture
was assayed in 190 ml of assay buffer consisting of 34 mM Tris–HCl (pH 7.5), 102 mM NaCl, 1.37 mM MgCl2,
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0.13 mM NADP+ and 0.13 mM isocitrate. The reaction was started by the addition of isocitrate, and
NADP-dependent IDH activity was determined by measuring the increase in absorbance of NADPH at
340 nm at RT for 10 min using a Tecan plate reader.
PDK2 assay
HEK293 cells were transfected with pCMV6-Entry/FLAG-PDK2; 48 h after transfection, cells were collected
and lysed in reducing lysis buffer [50 mM Tris–HCl (pH 7.5), 150 mM NaCl, 5 mM EDTA, 50 mM NaF,
5 mM Na4P2O7, 1% Triton X-100, PIC and 1 mM DTT]. The lysate was centrifuged at 21 000 g for 10 min at
4°C, and the concentration of the supernatant was measured by the Bradford assay. The protein and DTT con-
centrations of the supernatant were adjusted with lysis buffer to 3 mg/ml and 0.5 mM, respectively, and 0.15 ml
was incubated with 2 mg of anti-FLAG antibody (Sigma–Aldrich) and 10 ml of Protein G Sepharose for 4 h at
4°C. The immunoprecipitates were collected by centrifugation (956 g for 30 s) and washed/recentrifuged once
with 0.4 ml of lysis buffer without DTT and then with 0.2 ml of TBS. The immunoprecipitates were incubated
with or without 1 mM GSSG or CoASSCoA in 50 ml of TBS for 20 min at RT. Beads were pelleted by centrifu-
gation (956 g for 30 s) and washed/recentrifuged twice with 0.4 ml of cold TBS. FLAG-PDK2 was eluted by
incubating the beads for 30 min at 4°C with 15 ml of PDK2 elution buffer [50 mM KH2PO4 (pH 7.6), 0.3 mM
EDTA, 10 mM 2-glycerophosphate and 0.2 mg/ml FLAG peptide (Sigma–Aldrich)]. Beads were pelleted by
centrifugation as above and 15 ml of the supernatant was collected and mixed with 10 ml of pyruvate dehydro-
genase (PDH; from porcine heart, Sigma–Aldrich #P7032) that had been diluted to 1.3 mg/ml in 10 mM Tris–
HCl (pH 7.5) and desalted twice using desalting spin columns (MWCO 7000 Da, Thermo Scientiﬁc). PDK2
activity was measured by the incorporation of 33P from γ-33P ATP (New England Nuclear) into the E1 subunit
of the PDH complex in the presence or absence of 2 mM DTT. The reaction was started by the addition of
5 ml of ATP/Mg mix (150 mM ATP, 2 mCi γ-33P ATP and 30 mM MgCl2). After incubating for 10 min at RT,
the reaction was stopped by the addition of 14 ml of 4× loading buffer and 2 ml of 300 mM DTT. Samples were
heated at 99°C for 5 min and proteins were separated by SDS–PAGE. The incorporation of 33P into PDH was
visualised by autoradiography (Fuji Film Image Reader FLA-2000), and band intensities were quantiﬁed using
the MultiGauge software.
Quantiﬁcation of CoA in cells and tissues
These were measured by HPLC as previously described, except that 3.5% PCA was used to extract CoA from
tissues/cells and EDTA was omitted from the injection mixture [27].
Quantiﬁcation of protein-bound CoA
HEK293/Pank1β cells were treated with various oxidising agents and collected as described. Cells were lysed in
0.3 ml of lysis buffer supplemented with PIC, 25 mM NEM and 1% SDS, and sonicated to reduce viscosity.
Lysates were centrifuged at 21 000 g for 5 min at RT and proteins in the supernatant were precipitated by the
addition of methanol (80% ﬁnal, v/v). Samples were vigorously vortexed and centrifuged at 21 000 g for 3 min.
The supernatant was discarded and the pellet was washed with 1 ml of 80% methanol using a handheld tissue
tearor (Biospec Products). Proteins were pelleted again by centrifugation (21 000 g for 5 min at room tempera-
ture), the supernatant was discarded and the pellet was washed again as above. Proteins were pelleted again by
centrifugation (21 000 g for 5 min at room temperature) and the supernatant was discarded. Residue methanol
was removed by placing samples in a heating block for a few minutes. The pellet was solubilised in 45 ml of
reducing resolubilisation buffer consisting of 89 mM TEA, 0.44 mM KOH and 11.1 mM DTT by gentle sonic-
ation. After incubation for 5 min at RT, proteins were precipitated by the addition of 22 ml of 5% PCA and pel-
leted by centrifugation at 21 000 g for 10 min at 4°C. The supernatant was collected, and the pH was adjusted
to 6–7 with 0.5 M K2CO3 and centrifuged again at 21 000 g for 10 min at 4°C. A 50 ml aliquot of the super-
natant was used for CoA measurement by a modiﬁcation of the recycling assay described by Allred and Guy
[28] as follows. Neutralised samples were made up to a total volume of 160 ml in wells of a 96-microtiter plate
which additionally contained 375 mM Tris–HCl (pH 7.2), 75 mM KCl, 15 mM malate, 6 mM acetylphosphate,
1.5 mM NAD+, malate dehydrogenase (1 unit) and citrate synthase (1 unit). After incubation at RT for 10 min,
the reaction was started by the addition of 40 ml of phosphotransacetylase (3.5 units) and the rate of NADH
production at 30°C was monitored for 20 min at 340 nm using a Tecan plate reader. The amounts of CoASH
in samples were determined by measuring the rate of NADH production by CoA standard (Sigma–Aldrich)
diluted in reducing buffer which had been treated with 5% PCA and neutralised as described above. To
© 2017 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY-NC-ND).2493
Biochemical Journal (2017) 474 2489–2508
DOI: 10.1042/BCJ20170129
determine the total amount of protein from which CoA was released, the PCA pellets were washed with 1 ml of
0.1% PCA and resuspended in 0.2 ml of resolubilisation buffer by sonication, and protein concentration was
determined by the BCA assay (Thermo Scientiﬁc).
CoASSG preparation
CoASSG was produced by incubating oxidised GSH with reduced CoA in 50 mM Tris–HCl (pH 8) for 30 min
at 30°C. The reaction mixture was analysed by HPLC under the same conditions as those used for CoA mea-
surements [27]. The GSSCoA peak was collected and desalted with a PD10 column (MWCO700, GE
Healthcare).
Puriﬁcation and activity assay of Nudix 7 hydrolase
Recombinant His-Nudix 7 hydrolase was expressed in bacteria and puriﬁed by Ni-NTA afﬁnity chromatog-
raphy. His-Nudix 7 (1.7 mg) was incubated in a total volume of 100 ml containing 50 mM (NH4)HCO3 and
0.2 mM CoASSG at 37°C for 20 min with or without 5 mM MgCl2. Reaction products and substrates were
analysed by HPLC as described except that elution was monitored at 205 nm [27]. Peaks for 30,50-ADP, 4-
phosphopantetheinyl GSH and CoASSG were identiﬁed by comparison of retention times with those of
authentic standards.
Preparation and enrichment of CoAlated peptides from H2O2-treated heart for
MS analysis
Frozen, powdered heart was homogenised in ice-cold buffer containing 10 mM
3-[4-(2-hydroxyethyl)-1-piperazinyl] propanesulfonic acid, 150 mM NaCl, 1 mM EDTA, 1 mM NaF, 1 mM
Na3VO4, 10 mM Na4P2O7, 1 mM 2-glycerophosphate, 25 mM NEM and PIC using a tissue disintegrator.
Triton X-100 was added (1% ﬁnal), and the homogenate was mixed well and centrifuged at 21 000 g for 3 min
at 4°C. Proteins in the supernatant were precipitated with 90% methanol. The protein pellet was resuspended
in 50 mM (NH4)HCO3 (pH 7.8) supplemented with 6.4 mM iodoacetamide (IAM) and digested with Lys C
and trypsin (sequencing grade, Promega). The digestive enzymes were heat-inactivated (99°C, 10 min) and
CoAlated peptides were immunoprecipitated with anti-CoA antibody cross-linked to Protein G Sepharose.
Immunoprecipitated peptides were eluted with 0.1% triﬂuoroacetic acid and dried completely in a speed vac
concentrator. The resulting pellet was resolubilised in 50 mM (NH4)HCO3 and 5 mM MgCl2, and 1.7 mg of
Nudix 7 was added. The solution was incubated at 37°C for 20 min and then acidiﬁed, desalted with a C18
Stage tip that contained 1.5 ml of Poros R3 resin and partially dried in a speed vac concentrator before LC–MS/
MS analysis.
Preparation and enrichment of CoAlated peptides from liver mitochondria for
MS analysis
Liver mitochondria were prepared using a modiﬁcation of the method by Fernández-Vizarra et al. [29]. Brieﬂy,
pieces of liver were homogenised in isolation buffer (0.32 M sucrose, 1 mM EDTA, 25 mM NEM and 10 mM
Tris–HCl, pH 7.4) and centrifuged for 5 min at 1000 g at 4°C. The supernatant was collected and centrifuged
for 2 min at 15 000 g at 4°C. The pellet was resuspended in isolation buffer and centrifuged again as above, and
the resulting pellet containing mitochondria was snap-frozen and stored in liquid N2. Mitochondria were lysed
in lysis buffer supplemented with 25 mM NEM and PIC and centrifuged at 21 000 g for 10 min at 4°C. Soluble
proteins were separated by SDS–PAGE as above, and the 37–50 kDa area was cut out and proteins were eluted
in elution buffer [50 mM Tris–HCl (pH 7.5), 150 mM NaCl, 0.1 mM EDTA, 0.1% SDS and 20 mM NEM] on
a rotating wheel for 6 h at 4°C. Eluted proteins were precipitated and washed with 90% methanol. The protein
pellet was digested with trypsin and CoAlated peptides were immunoprecipitated using anti-CoA antibody as
above. Immunoprecipitated peptides were treated with Nudix 7 and enriched further by an IMAC column
before LC–MS/MS analysis.
Mass spectrometry data acquisition
The enzymatic digests were analysed by nano-scale capillary LC-MS/MS using an Ultimate U3000 HPLC
(ThermoScientiﬁc Dionex, San Jose, USA) to deliver a ﬂow of approximately 300 nl/min. A C18 Acclaim
PepMap100 5 mm, 100 mm× 20 mm nanoViper (ThermoScientiﬁc Dionex, San Jose, USA) trapped the
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Figure 1. Protein CoAlation is induced by oxidative stress in mammalian cells and the extent of modiﬁcation is
determined by cellular levels of CoA. Part 1 of 2
(A) Top, structure of CoA. Bottom, western blot demonstrating speciﬁcity of anti-CoA antibody. CoA, dpCoA and 4PP were
conjugated to BSA through disulphide linkage and analysed by anti-CoA immunoblot in the presence and absence of DTT.
(B) Anti-CoA western blot reveals extensive modiﬁcation of cellular proteins by CoA in rat cardiomyocytes in response to
various oxidising agents. (C) Adult rat cardiomyocytes were untreated or treated with the indicated concentrations of H2O2 for
30 min, and protein CoAlation was examined by anti-CoA immunoblot. (D) The patterns of proteins modiﬁed by CoAlation and
glutathionylation in response to H2O2 are distinct. Isolated rat hearts were perfused in the presence or absence of 100 mM
H2O2 for 20 min, and protein CoAlation and glutathionylation were examined by immunoblotting with anti-CoA or anti-GSH
monoclonal antibodies. (E) Comparison of CoA levels in rat tissues, primary and established cell lines. Data are mean ± SEM of
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peptides prior to separation on a C18 Acclaim PepMap100 3 mm, 75 mm× 250 mm nanoViper
(ThermoScientiﬁc Dionex, San Jose, USA). Peptides were eluted with a gradient of acetonitrile. The analytical
column outlet was directly interfaced via a modiﬁed nano-ﬂow electrospray ionisation source, with a hybrid
dual pressure linear ion trap mass spectrometer (Orbitrap Velos, ThermoScientiﬁc, San Jose, USA). Data
dependent analysis was carried out, using a resolution of 60,000 for the full MS spectrum, followed by 20 MS/
MS spectra in the linear ion trap. MS spectra were collected with an automatic target gain control of 1 × 106
and a maximum injection ﬁll time of 250 ms over a m/z range of 350–1600. MS/MS scans were collected using
an automatic gain control value of 1 × 104 and a threshold energy of 35 for collision induced dissociation. The
Orbitrap measurements were internally calibrated using the lock mass of polydimethylcyclosiloxane at m/z
445.120025.
Data processing
LC–MS/MS raw data ﬁles were processed as a single unlabelled sample using MaxQuant [30] version 1.5.2.8,
which incorporates the Andromeda search engine. For all data sets, the default parameters in MaxQuant were
used, except for MS/MS tolerance at 0.6 Da and that the second peptide ID was unselected.
Carbamidomethylation of cysteine and the N-terminus, N-ethylmaleimide cysteine, oxidation of methionines,
CoAlation of cysteine with delta mass values 338, 356 and 765 were allowed as variable modiﬁcations.
MaxQuant-processed data were searched against a protein sequence database (Uniprot KB-human, June 2013)
database.
Using MQ viewer, CoA_356 peptides were ﬁrst visually checked and those MS/MS scans that ‘failed’ visually
were checked manually. The corresponding MS/MS scan was manually sequenced to match the identiﬁed
peptide.
Statistical analysis
Where appropriate, values are given as means ± SEM. Statistical signiﬁcance was determined by a one-way or
two-way ANOVA with correction for multiple comparisons as speciﬁed in the ﬁgure legends. Differences were
considered signiﬁcant at the 5% level. Graphs were produced and statistics were calculated using GraphPad
Prism version 6.07 for Windows (GraphPad Software, La Jolla, CA, U.S.A., www.graphpad.com).
Results
Extensive modiﬁcation of cellular proteins by CoA in response to oxidative
stress
The identiﬁcation of the post-translational modiﬁcation of cellular proteins by CoA has been hampered by the
lack of speciﬁc antibodies that would allow its detection, in contrast with the availability of protocols to study
phosphorylated, acetylated or glutathionylated proteins. We have recently developed a highly speciﬁc anti-CoA
monoclonal antibody 1F10 which recognises CoA in various immunological assays [24]. Western blot analysis
of BSA alone and the BSA-CoA, BSA-dpCoA and BSA-4PP (40-phosphopantetheine) disulphide conjugates
with 1F10 antibody showed speciﬁc recognition of BSA-CoA in a DTT-sensitive manner (Figure 1A). Since the
BSA-dpCoA disulphide conjugate is not recognised by the 1F10 antibody, we can conclude that the
30-phosphate of the deoxyribose ring is part of the epitope for the given antibody. Further characterisation of
this antibody in western blot analysis of protein extracts from mammalian cells and tissues revealed under
non-reducing conditions many immunoreactive bands, suggesting covalent binding of CoA to cellular proteins.
The above ﬁndings and the identiﬁcation of several eukaryotic and prokaryotic proteins with covalently bound
CoA [23,20,21] prompted us to investigate in mammalian cells and tissues the extent of protein thiol
Figure 1. Protein CoAlation is induced by oxidative stress in mammalian cells and the extent of modiﬁcation is
determined by cellular levels of CoA. Part 2 of 2
at least three biological replicates (n = 5 for cardiomyoctes and HEK293; n = 4 for HepG2 (hepatocellular carcinoma) and MEF
(mouse embryonic ﬁbroblasts); n = 3 for the rest). (F) Protein CoAlation is induced by H2O2 in HEK293/Pank1β, but not in
parental HEK293 cells. (G) HEK293/Pank1β cells were incubated with the indicated concentrations of H2O2 for 10 min, and
protein CoAlation was examined by anti-CoA immunoblot. (H) HEK293/Pank1β cells were incubated with 250 mM H2O2 for the
indicated times, and protein CoAlation was examined by anti-CoA immunoblot.
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modiﬁcation by CoA (which we have termed CoAlation) under various experimental conditions. Initially, we
examined whether oxidising agents can induce protein CoAlation in primary adult rat cardiomyocytes, which
contain high levels of CoA. The treatment of isolated cardiomyocytes for 30 min with the oxidising agents
H2O2, TBH or menadione, or with the thiol-selective oxidant diamide, all resulted in extensive immunoreactiv-
ity with the anti-CoA antibody when cell lysates were examined by western blot under non-reducing conditions
(Figure 1B). Notably, most of the immunoreactive bands were not detected when protein samples were sepa-
rated under reducing conditions (100 mM DTT), suggesting the formation of mixed disulphides between CoA
and cellular proteins. There was one major DTT-insensitive immunoreactive band, which is likely to be due to
non-speciﬁc binding of antibodies. To further validate these ﬁndings, isolated cardiomyocytes were treated with
increasing concentrations of H2O2. As shown in Figure 1C, treatment of cardiomyocytes with H2O2 increased
protein CoAlation in a dose-dependent manner, with the effect being most pronounced at 100 mM H2O2,
while several immunoreactive bands were detected at as low as 1 mM H2O2.
These ﬁndings encouraged us to employ the Langendorff-perfused heart model for studying protein
CoAlation in rat heart exposed to oxidative stress. This model has been employed extensively to study redox
regulation and protein S-thiolation. We found that perfusing rat hearts with 100 mM H2O2 for 20 min signiﬁ-
cantly increased protein CoAlation, which was reversed to the level of untreated control by DTT (Figure 1D).
Immunoblotting the same samples with anti-GSH monoclonal antibody D8 also showed extensive glutathiony-
lation of cellular proteins in a DTT-sensitive manner (Figure 1D). Interestingly, the patterns of proteins modi-
ﬁed by these post-translational modiﬁcations varied signiﬁcantly, suggesting differential targeting of cysteine
thiols in cellular proteins by CoA and GSH in response to oxidative stress.
Analysis of CoASH concentrations in rat tissues, and primary and established cell lines revealed that primary
cardiomyocytes, kidney, liver and heart contain much higher concentrations of CoASH when compared with
HepG2 and HEK293 (Figure 1E). We were interested to ﬁnd whether the extent of protein CoAlation is deter-
mined by the cellular level of CoASH. The treatment of exponentially growing HEK293 cells with 500 mM
H2O2 showed no signiﬁcant increase in protein CoAlation (Figure 1F). To test whether increasing the concen-
tration of CoA in HEK293 cells can augment protein CoAlation in response to H2O2, we generated HEK293
cells with stable overexpression of Pank1β. It has been shown that the overexpression of Pank1β, the main rate-
limiting enzyme in CoA biosynthesis, signiﬁcantly increases CoA levels in Cos7 cells [31]. A markedly
increased protein CoAlation was observed in HEK293/Pank1β cells treated with 500 mM H2O2 (Figure 1F).
Many proteins were also CoAlated in untreated cells. As in cardiomyocytes, the effect of H2O2 on protein
CoAlation in HEK293/Pank1β cells was dose-dependent (Figure 1G). In a time-course study, we found that
CoAlated proteins are detected in HEK293/Pank1β cells as early as 5 min after H2O2 treatment (Figure 1H).
The HEK293/Pank1β cell model was further used to examine protein CoAlation in response to a diverse
range of oxidising agents. The present study revealed extensive protein CoAlation in response to H2O2,
diamide, menadione and TBH; however, only a few proteins were shown to be CoAlated in cells treated with
PAO to block vicinal dithiols (Figure 2A). The extensive protein CoAlation in response to several oxidising
agents led us to quantify the level of protein-bound CoA in HEK293/Pank1β cells treated with or without oxi-
dising agents. The determined values of protein-bound CoA (Figure 2B) correlated to the intensity of anti-CoA
immunoreactive bands in HEK293/Pank1β cells treated with the same panel of oxidising agents (Figure 2A). A
low level of CoA (30 ± 3 pmol/mgprotein, n = 6) was extracted from the total protein of untreated cells, while
treatment with oxidising agents resulted in a 2- to 12-fold increase in protein-bound CoA (H2O2: 98 ± 2 pmol/
mgprotein n = 3; menadione: 149 ± 7 pmol/mgprotein n = 3; PAO: 58 ± 4 pmol/mgprotein n = 6; diamide: 355 ±
14 pmol/mgprotein, n = 6; TBH: 135 ± 11 pmol/mgprotein n = 3).
Protein CoAlation is a reversible post-translational modiﬁcation
Covalent protein modiﬁcations, such as phosphorylation, acetylation and glutathionylation, are reversible regu-
latory events. To establish whether protein CoAlation is a reversible post-translational modiﬁcation, HEK293/
Pank1β cells were treated with 500 mM H2O2 for 60 min and then left to recover for various periods of time in
complete growth medium. As shown in Figure 2C, the H2O2-mediated increase in protein CoAlation in
HEK293/Pank1β cells was reversed to basal levels in a time-dependent manner. Surprisingly, a signiﬁcant
decrease in protein CoAlation occurs within 5 min after removal of H2O2 and reaches baseline levels within
90 min. The reversibility of protein CoAlation was also observed in diamide-treated HEK293/Pank1β cells after
the removal of the oxidising agent (Figure 2D). These data suggest that protein de-CoAlation is a fast event
initiated as soon as the oxidative stress is removed.
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Oxidative stress in cells is closely associated with the activation of antioxidant defence systems, which keep
oxidants at an optimum level. Therefore, we examined whether protein CoAlation induced by oxidising agents
could be prevented by pretreatment of cells with known antioxidants, such as N-acetyl-L-cysteine (NAC) and
Figure 2. Protein CoAlation is a reversible post-translational modiﬁcation and it is prevented by antioxidants.
(A) Anti-CoA western blot showing extensive protein CoAlation in HEK293/Pank1β in response to various oxidising agents.
(B) Quantitation of protein-bound CoA after the treatment of HEK293/Pank1β cells with oxidising agents (related to Figure 2A).
Values and error bars represent mean ± SEM of at least three independent experiments (n = 6 for control, PAO and diamide;
n = 3 for the rest). *P < 0.001 compared with the control group by one-way ANOVA followed by Dunnett’s post hoc analysis to
correct for multiple comparisons. (C and D) Diamide- and H2O2-induced protein CoAlation in HEK293/Pank1β cells is reversed
upon removal of the oxidants. HEK293/Pank1β cells were treated with 250 mM H2O2 and 0.5 mM diamide for 30 min. The
medium was then replaced with fresh media without the oxidants and cells were incubated for the indicated times. Protein
CoAlation was examined by anti-CoA immunoblot. (E) Protein CoAlation is prevented by antioxidants. HEK293/Pank1β cells
were pretreated for 2 h with NAC or Vitamin C before treatment with 0.5 mM diamide for 30 min. Protein CoAlation was
examined by anti-CoA western blotting.
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Figure 3. Induction of protein CoAlation by metabolic stress.
(A) HEK293/Pank1β cells were incubated in pyruvate (pyr) and glucose (glu)-free DMEM medium alone or supplemented with 5
or 20 mM pyruvate. Protein CoAlation was analysed by anti-CoA immunoblot. (B) HEK293/Pank1β cells were incubated in
complete pyruvate and glucose-free DMEM alone or supplemented with different concentrations of glucose. Protein CoAlation
was analysed by anti-CoA immunoblot. (C) HEK293/Pank1β cells were incubated in pyruvate and glucose-free DMEM alone or
supplemented with different concentrations of glucose (glu), galactose (galac), lactate (lac) or acetate (acet). Protein CoAlation
was analysed by anti-CoA immunoblot. (D) Induction of protein CoAlation in rat liver after fasting for 24 h. (E) Feeding HF/HS
diet for 1 week reduces protein CoAlation in rat liver. (F) Protein CoAlation is decreased in the livers of ob/ob mice. Data are
mean ± SEM of three (D and E) or six (F) biological replicates. *P < 0.05 by one-way ANOVA.
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Vitamin C. We found that incubation of HEK293/Pank1β cells with 5 mM NAC for 2 h before diamide treat-
ment largely prevented protein CoAlation induced by 0.5 mM diamide (Figure 2E). The effect of Vitamin C
(1 mM) was less pronounced, resulting in ∼50% decrease in anti-CoA immunoreactivity.
Protein CoAlation is induced by metabolic stress
We consistently observed a low level of DTT-sensitive immunoreactivity with the anti-CoA antibody when
samples of exponentially growing HEK293/Pank1β cells were analysed by Western blot (Figure 1F–H). In add-
ition, a small amount of CoA could be extracted with DTT from the total protein fraction of untreated
HEK293/Pank1β cells (Figure 2B). These observations show that some proteins are CoAlated in cells even in
the absence of exogenously added oxidants. Interestingly, this basal CoAlation of cellular proteins was increased
in cells cultured in media lacking glucose and pyruvate (Figure 3A). The induction of protein CoAlation in
pyruvate- and glucose-deprived cells was reversed by the re-addition of glucose or pyruvate, and the effect was
concentration-dependent (Figure 3A,B). Moreover, galactose, lactate and acetate, which are used less efﬁciently
by mammalian cells as an energy source, were less capable of reducing protein CoAlation in pyruvate- and
glucose-deprived cells (Figure 3C). These observations led us to examine the effect of fuel utilisation and meta-
bolic stress on protein CoAlation in animal models under physiological and pathological metabolic conditions.
As shown in Figure 3D, protein CoAlation in the rat liver was signiﬁcantly induced after fasting for 24 h. These
results suggest that protein CoAlation is induced not only by oxidising agents, but also occurs when liver is
under metabolic stress induced by starvation. Changes in protein CoAlation were also detected in the liver
under pathologically relevant conditions of metabolic syndrome. We found that feeding HF/HS diet for 1 week
resulted in a substantial decrease in protein CoAlation in rat liver (Figure 3E). In agreement with the above
ﬁnding, protein CoAlation was also markedly decreased in the liver of genetically obese ob/ob mice compared
with wild-type littermate mice (Figure 3F).
Identiﬁcation of CoAlated proteins by mass spectrometry
Extensive protein CoAlation induced by oxidising agents and metabolic stress in mammalian cells and
tissues, and the availability of 1F10 antibody led us to develop a strategy for the identiﬁcation of
CoA-modiﬁed proteins. We have previously demonstrated that the 1F10 antibody speciﬁcally precipitated
BSA-CoA conjugate, but with low efﬁciency [24]. Taking this into account, we prepared a CoA-glutahione
disulphide (CoASSG) heterodimer and showed that the 1F10 antibody could effectively immunoprecipitate
the CoASSG heterodimer in a concentration-dependent manner (results not shown). Initially, we employed
the following methodology for the identiﬁcation of CoAlated peptides by LC–MS/MS. Isolated rat hearts
were perfused with 100 mM H2O2 for 20 min and total lysates were prepared in the presence of 25 mM NEM
to block free thiols. Protein was extracted by methanol precipitation and digested with Lys-C/trypsin in the
presence of IAM. Then, CoAlated peptides were immunoprecipitated with 1F10 antibody cross-linked to
Protein G Sepharose. The eluted peptides were analysed by LC–MS/MS. Protein database searches using the
MaxQuant Andromeda software [30], set to include a post-translational cysteine modiﬁcation showing an
increase in 765 Da, corresponding to covalently bound CoA (CoA: 767.535 Da), initially only returned a few
matching fragment ion spectra. This was because of the fragmentation of CoAlated peptides (Cys + 765)
during LC–MS/MS, giving rise to a characteristic neutral loss of m/z 428 and m/z 508 from the parent ion
with very little peptide backbone fragmentation (Figure 4A). Therefore, to improve the identiﬁcation of
CoAlated peptides, we cleaved off the 30,50-ADP moiety of CoA responsible for the neutral loss fragment
ions. To do this, CoAlated peptides were eluted from immune complexes and digested with Nudix7 (Nudix
hydrolase 7). Nudix7 belongs to the family of phosphohydrolases and functions as a CoA/acyl CoA dipho-
sphatase [32]. The LC–MS/MS analysis of CoAlated peptides digested with Nudix7 is expected to show an
increase in 356 Da, corresponding to covalently attached 4PP (Figure 4B). Indeed, the digestion of immuno-
precipitated CoA-modiﬁed peptides with Nudix7 results in a distinctive MS/MS fragmentation signature of
Cys + 356. Representative MS/MS spectra of cysteine-containing peptides from H2O2-treated hearts are
shown in Figure 4C,D.
The developed protocol allowed us to identify in rat heart perfused with 100 mM H2O2 for 20 min a
total of 80 CoAlated peptides that matched to 58 proteins (Supplementary Table S1). In addition, 43
CoAlated peptides corresponding to 33 proteins were identiﬁed in the liver mitochondria prepared from a
24 h starved rat (Supplementary Table S2). Bioinformatic pathway analysis of identiﬁed proteins showed
that they are implicated in a diverse range of cellular processes, including intermediate metabolism,
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Figure 4. Proteomic identiﬁcation of CoAlated proteins in H2O2-treated heart and in the liver of starved rats. Part 1 of 2
(A) LC–MS/MS spectrum of a CoAlated peptide derived from heart protein, showing an increase in 765 Da, corresponding to
covalently bound CoA. The inset (a) shows the structure of CoA and indicates the neutral loss of the ATP moiety (m/z 507 and
427), which can occur under CID (collision-induced dissociation) fragmentation of the precursor ion. The major ions identifying
these neutral losses are annotated on the spectrum. (B) Nudix7 cleaves the diphosphate bond of CoA, generating a unique
signature for MS/MS analysis. (C and D) Examples of the MS/MS spectra of CoA-modiﬁed peptides, corresponding to
mitochondrial S-type CK 2 (CKMT2) and GAPDH. Proteins identiﬁed to be CoAlated in H2O2-treated heart (E) and liver
mitochondria of a 24 h-starved rat (F) were grouped into major functional categories. See Supplementary Tables S1 and S2 for
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protein synthesis, muscle contraction and stress response (Figure 4E,F). A large number of CoAlated pro-
teins are involved in major metabolic pathways, such as the Krebs cycle, β-oxidation, metabolism of
glucose, amino acids and ketone bodies, in which CoA and its derivatives are central cofactors and meta-
bolites (Figure 4G). The high prevalence of metabolic enzymes in this analysis is not due to the abun-
dance of these proteins, because similarly abundant ribosomal proteins were not found to be CoAlated
(Supplementary Tables S1 and S2).
CoAlation preferentially targets metabolic enzymes
The susceptibility of metabolic enzymes to CoAlation in response to oxidative and metabolic stress may reﬂect
a potential regulatory or feedback mechanism in which these pathways respond to the CoA/acyl CoA redox
state. Therefore, we investigated CoAlation of several enzymes from different metabolic pathways in vitro and
in vivo and examined the effect of this modiﬁcation on their activities. Initially, we tested whether a set of
selected enzymes could be CoAlated in vitro. In the present study, recombinant preparations of aconitase 2
(Aco2), HMGCS2, IDH2 and PDK2, as well as CK and GAPDH puriﬁed from skeletal muscle, were incubated
with or without CoA disulphide (CoASSCoA). Western blot analysis of reaction mixtures with the 1F10 anti-
body revealed a strong immunoreactive signal corresponding to all tested proteins only in samples incubated
with CoA disulphide (Figure 5A). No immunoreactivity was detected in samples separated under reducing con-
ditions (100 mM DTT). Coomassie staining of analysed samples showed that the mobility of Aco2, IDH2,
HMGCS2 and PDK2 was retarded when CoA disulphide was present in the reaction mixtures. The addition of
DTT completely abolished the observed electrophoretic mobility shifts, indicating the formation of CoA–
protein mixed disulphides.
To validate CoAlation of proteins identiﬁed by mass spectrometry, we investigated CoAlation of a set of
metabolic enzymes in response to oxidative stress in cells. HEK293/Pank1β cells were transiently transfected
with plasmids encoding FLAG-tagged forms of CK, GAPDH, IDH2 and PDK2, and then treated with H2O2 or
diamide. Immunoprecipitation of transiently expressed FLAG-tagged CK, GAPDH, IDH2 and PDK2 followed
by immunoblotting with the 1F10 antibody conﬁrmed that all tested proteins are indeed CoAlated in cells
treated with H2O2 or diamide (Figure 5B). Furthermore, CoAlation of several endogenous proteins was exam-
ined in heart and liver under various experimental conditions. Immunoprecipitation of endogenous ACAA2
from the liver of control and starved rats revealed starvation-induced CoAlation of ACAA2 (Figure 5C). In con-
trast, CoAlation of endogenous HMGCS2 was at a high level in the liver of rats kept on a chow diet, but
feeding rats a HF/HS diet for 1 week resulted in a substantial decrease in HMGCS2 CoAlation (Figure 5D).
ACAA2 and HMGCS2 are key enzymes in β-oxidation and ketogenesis, respectively, so CoAlation of these
enzymes may regulate fatty acid oxidation and ketone bodies formation during prolonged starvation or excess
supply of nutrients.
Next, we speciﬁcally investigated the effect of in vitro CoAlation on the activity of CK, GAPDH, IDH2 and
PDK2. In the heart, CK is an important source of ATP production and its inactivation is thought to play a
critical role in cardiac response to oxidative stress and reperfusion injury [33]. CK is inhibited by GSSG in a
Figure 4. Proteomic identiﬁcation of CoAlated proteins in H2O2-treated heart and in the liver of starved rats. Part 2 of 2
full lists of identiﬁed proteins. (G) Major metabolic enzymes are CoAlated in H2O2-treated heart (blue circles) and liver
mitochondria of a 24 h-starved rat (red circles), ACC, acetyl CoA carboxylase; MCD, malonyl CoA decarboxylase; CPT1,
carnitine palmitoyl transferase 1; CACT, carnitine/acylcarnitine carrier protein; DH, dehydrogenase; CS, citrate synthase; IDH,
isocitrate dehydrogenase; OGDH, oxoglutarate dehydrogenase; SDH, succinyl-CoA dehydrogenase; MDH, malate
dehydrogenase; PDK, pyruvate dehydrogenase kinase; PDH, pyruvate dehydrogenase; GAPDH, glyceraldehyde 3-phosphate
dehydrogenase; SCOT, succinyl-CoA: 3-ketoacid CoA transferase; ACAT1, acetyl-CoA acetyltransferase; I-IV, electron transport
chain complexes I–IV; Q, coenzyme Q; CytC; cytochrome C; F0/F1, ATP synthase; ANT, adenine nucleotide translocase; CK,
creatine kinase; BDH1, D-β-hydroxybutyrate dehydrogenase; HMGCL, hydroxymethylglutaryl-CoA lyase; HMGCS2,
hydroxymethylglutaryl-CoA synthase; ALDH4A1, Δ-1-pyrroline-5-carboxylate dehydrogenase; ALDH5A1,
succinate-semialdehyde dehydrogenase; ALDH6A1, methylmalonate-semialdehyde dehydrogenase [acylating]; ALDH7A1,
α-aminoadipic semialdehyde dehydrogenase; Glud1, glutamate dehydrogenase 1; Got2, aspartate aminotransferase; GSTZ1,
maleylacetoacetate isomerise; HIBADH, 3-hydroxyisobutyrate dehydrogenase; Kat3, kynurenine–oxoglutarate transaminase 3;
PCCA, propionyl-CoA carboxylase. Larger-format versions of panels A-G are available in the Supplementary Material.
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dose-dependent manner [34], with the site of glutathionylation mapped to Cys283. In agreement with this
report, we observed full inhibition of CK activity by GSSG which is reversed by DTT (Figure 6A). Notably,
the activity of CK was also completely inhibited by incubation with CoASSCoA and the recovery was
Figure 5. In vitro and in vivo CoAlation of metabolic enzymes.
(A) In vitro CoAlation of a panel of metabolic enzymes. Recombinant preparations of aconitase, IDH2, PDK2, HMGCS2, as well
as CK and GADPH puriﬁed from skeletal muscle were incubated with 2–10 mM CoA dimer (CoASSCoA). NEM (25 mM) was
added and samples were heated in loading buffer with or without DTT. CoAlation of enzymes was examined by anti-CoA
immunoblot. (B) FLAG-tagged CK muscle isoform, GAPDH, IDH2 and PDK2 were transiently overexpressed in HEK293/
Pank1β. Transfected cells were treated for 30 min with 0.5 mM H2O2 or 0.5 mM diamide. Overexpressed proteins were
immunoprecipitated with an anti-FLAG antibody and immune complexes immunoblotted with anti-CoA antibody. (C and D)
Endogenous ACAA2 and HMGCS2 were immunoprecipitated from the liver of control, 24 h starved rats or rats that were fed HF/
HS diet for 1 week and analysed by anti-CoAWestern blotting. Data are mean ± SEM of three biological replicates. *P < 0.05.
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Figure 6. Catalytic activities of CK, GAPDH, IDH and PDK2 are modulated by CoAlation.
(A–D) CK, GAPDH puriﬁed from skeletal muscle and NADP-dependent IDH puriﬁed from heart were incubated with CoASSCoA
or GSH dimer (GSSG) and their enzymatic activities assayed spectrophotometrically. The activity of recombinant PDK2 puriﬁed
from HEK293 cells was assayed radiometrically using PDH as the substrate. Data shown are mean ± SEM of 3 (A, C and D) or
5 (B) independent measurements. Differences between groups were evaluated by a two-way repeated measures ANOVA
matching both factors followed by a Tukey post hoc test to correct for multiple comparisons when assessing simple effects or
Sidak test when assessing the ‘reducing agent’ effect. *P < 0.05. ns, not signiﬁcant. (E) Cellular functions of CoA. In addition to
its well-established role as an essential metabolic cofactor, CoA may also function as an antioxidant in cellular response to
oxidative or metabolic stress via protein CoAlation.
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DTT-dependent. In H2O2-treated heart, we identiﬁed seven CoAlated peptides corresponding to CKB, CKM,
CKMT1 and CKMT2 (Supplementary Table S1), and their role in regulating the function of CK isoforms
remains to be elucidated.
GAPDH has a well-established role in glycolysis and is also implicated in the regulation of transcription, ini-
tiation of apoptosis and axonal transport [35]. GAPDH possesses a highly conserved catalytic cysteine, which
is a target for various thiol modiﬁcations, including sulfenylation, glutathionylation and nitrosation. These
modiﬁcations were shown to modulate its enzymatic activity and regulatory interactions. Here, we show that
CoAlation of GAPDH decreases activity in vitro by ∼75% and the inhibition is reversed by DTT (Figure 6B).
We also found inhibition of GAPDH activity by GSSG, but to a much lesser degree (15%). Cys23 and Cys245
were found to be CoAlated in GAPDH in the heart after H2O2 treatment. Cys23 is located in close proximity
to the NAD-binding pocket, so the modiﬁcation of this residue by CoA may affect the afﬁnity of interaction
with NAD through steric effects. Nitrosation of Cys245 in cellular response to interferon-γ and LDL(ox) was
implicated in the formation of the iNOS-S100A8/9 transnitrosylase complex [36]. The relevance of Cys23 and
Cys245 CoAlation in the function of GAPDH will be the subject of further studies.
Four CoAlated peptides, corresponding to the mitochondrial NADP-dependent IDH2, were identiﬁed in the
present study. IDH2 is a key player in intermediary metabolism and energy production, and catalyses the oxi-
dative decarboxylation of isocitrate into α-ketoglutarate in the Krebs cycle [37]. As shown in Figure 6C, the
incubation of IDH2 with CoASSCoA signiﬁcantly reduced its activity, which was restored in the presence of
DTT. The role of CoAlated cysteines in the function of IDH2 remains to be investigated although Cys113,
Cys418 and Cys308 are located in close proximity to the substrate and NADP-binding sites. It is important to
note that the addition of DTT to IDH2, GAPDH, CK and PDK2 increased their activity (Figure 6B–E). This
suggests that the enzyme preparations possess reversibly modiﬁed cysteine thiols which reduce their enzymatic
activities supporting a role in regulation.
PDK2 is an isozyme of PDH kinase which has an active site and an allosteric site co-operating for the activa-
tion and regulation of this enzyme. In its active state, PDK2 phosphorylates and inactivates the PDH complex,
which is a rate-limiting step in regulating glycolysis and carbohydrate oxidation as well as producing metabo-
lites for oxidative phosphorylation and the electron transport chain [38]. The activity of PDK2 towards PDH
has been previously shown to be inhibited by low levels of H2O2 in heart mitochondria via reversible oxidation
of Cys45 and Cys392 [39]. To our knowledge, S-thiolation of PDK2 by low-molecular-weight thiols such as
GSH has not been reported. In our study, Cys392 was found to be CoAlated in perfused heart in response to
H2O2 treatment (Supplementary Table S1). As shown in Figure 6D, in vitro CoAlation of recombinant PDK2
signiﬁcantly inhibited its activity and the phosphorylation of PDH was reversed by DTT. Notably, preincuba-
tion of PDK2 with oxidised GSSG did not affect its activity towards PDH.
The above ﬁndings reveal for the ﬁrst time that CoA, in addition to its well-established functions in cellular
metabolism, may play a major role in the regulation of oxidative and metabolic stress response (Figure 6E).
Discussion
CoA is at the heart of metabolic integration. CoA generates a diverse range of thioesters which are involved in
major metabolic pathways, cholesterol and acetylcholine biosynthesis, and the regulation of gene expression. In
the present study, we report a novel function of CoA in the control of cellular redox regulation mediated by
reversible covalent modiﬁcation of various cellular proteins. To be recognised as a redox-control mechanism,
protein CoAlation must meet several important criteria, including (a) induction by ROS and/or RNS; (b)
reversible modiﬁcation; (c) modulation of protein activity or function and (d) speciﬁcity to regulatory cysteine
residues. Here, we provide evidence that protein CoAlation is induced in a dose- and time-dependent manner
in mammalian cells treated with different oxidising agents. Secondly, the fast and reversible nature of protein
CoAlation is clearly observed when the oxidants are removed from cell cultures. It remains to be elucidated
whether the de-CoAlation process is enzymatically driven. Furthermore, protein CoAlation can be effectively
blocked by pretreatment of cells with antioxidants. Thirdly, the developed protocol allowed us to identify a
wide range of cellular proteins modiﬁed by CoA in hearts perfused with H2O2. A striking feature of redox-
regulated protein CoAlation is that it preferentially occurs on proteins involved in metabolic pathways. Finally,
a signiﬁcant difference in the patterns of CoAlated and glutathionylated proteins in H2O2-treated rat hearts
clearly suggests that different regulatory cysteine residues can be speciﬁcally targeted by CoA and GSH in
response to oxidative stress. To further substantiate these ﬁndings, we also demonstrated extensive
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oxidant-induced protein CoAlation in prokaryotes, especially in Staphylococcus aureus, which produces large
quantities of CoA, but lacks detectable levels of GSH (unpublished observation).
What is the relevance of protein CoAlation in the function of mammalian cells? Similarly to glutathionyla-
tion, protein CoAlation may function as an important antioxidant defence by preventing the formation of irre-
versible oxidation of the highly nucleophilic thiol group of cysteine residues located on the surface of cellular
proteins. Alternatively, CoAlation can directly regulate the activity of cellular enzymes in response to oxidative
or metabolic stress. We also propose that the presence of pantetheine and 3050-ADP moieties on CoA-modiﬁed
cysteines may generate a unique binding motif for intra- and inter-molecular interactions, especially for pro-
teins containing the Rossmann binding fold.
GSH has been regarded as the main modulator of the redox homeostasis in mammalian cells, and the role of
protein glutathionylation in the oxidative stress response has been extensively studied in the last two decades.
The present study reveals an alternative mechanism of redox regulation by protein CoAlation and lays a foun-
dation for delineating the role of this post-translational modiﬁcation under physiological and pathophysio-
logical conditions.
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